Antithrombotic treatment in atrial fibrillation patients undergoing PCI: Is dual therapy the winner?

Christos Mantis1, Dimitrios Alexopoulos2

  • 1Cardiology Department, Konstantopoulio General Hospital, Athens, Greece.

Thrombosis Research
|March 4, 2019
PubMed

Insights

Dual antithrombotic therapy (DAT) may be a safer alternative to triple antithrombotic therapy (TAT) for patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI). DAT reduces bleeding risk while maintaining similar efficacy for preventing ischemic events.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Atrial fibrillation affects approximately 7% of patients undergoing percutaneous coronary intervention (PCI) with stent implantation.
  • Optimal antithrombotic treatment in this high-risk population is a significant clinical challenge.
  • Triple antithrombotic therapy (TAT) is effective but associated with increased bleeding risk.

Purpose of the Study:

  • To define the role of dual antithrombotic therapy (DAT) versus TAT in patients with atrial fibrillation undergoing PCI.
  • To analyze controversial issues and future expectations regarding antithrombotic strategies.

Main Methods:

  • Review of recent clinical trials comparing DAT and TAT.
  • Analysis of efficacy and safety data, focusing on bleeding and ischemic events.
  • Expert opinion and consensus on simplified antithrombotic strategies.

Main Results:

  • Recent trials suggest DAT (single antiplatelet + oral anticoagulant) reduces bleeding risk compared to TAT (dual antiplatelet + oral anticoagulant).
  • DAT appears to maintain similar efficacy in preventing ischemic events as TAT.
  • A simplified DAT strategy using a non-vitamin K antagonist oral anticoagulant and clopidogrel is gaining expert support.

Conclusions:

  • DAT represents an attractive, simplified strategy for many patients with atrial fibrillation undergoing PCI.
  • Further research is needed to address remaining controversies and establish definitive guidelines.
  • Optimizing antithrombotic treatment balances efficacy and safety in this complex patient group.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.9K
Amyloid Fibrils03:03

Amyloid Fibrils

6.4K
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.4K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
612
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
423